TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Novartis at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
Novartis takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its program centres on peptides in radioligand therapy for precision targeting in oncology. It also opens the segment on peptide process development and manufacturing.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Swiss pharmaceutical company whose portfolio includes the siRNA drug inclisiran and peptide-based radioligand therapies. | Chair Wed Nov 4 13:55–14:00 Talk Wed Nov 4 11:15–11:45 Peptides in Radioligand Therapy: Precision Targeting in Oncology How peptides carry radioactive atoms straight to cancer cells, and what that means for manufacturing and quality control. |
Find decision makers at Novartis
Tell us what you sell and we’ll find the people at Novartis most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction